Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. - Wikidata - wikimedia - TriplyDB

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

http://www.wikidata.org/entity/Q33377856

about

Evaluation of the Effects of Vaccinium arctostaphylos L. Fruit Extract on Serum Lipids and hs-CRP Levels and Oxidative Stress in Adult Patients with Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Prognostic effect size of cardiovascular biomarkers in datasets from observational studies versus randomised trials: meta-epidemiology study Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease Risk assessment in the prevention of cardiovascular disease in low-resource settings Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis C-reactive protein and coronary heart disease: all said--is not it?Identifying novel biomarkers for cardiovascular disease risk prediction Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease Measuring hsCRP--an important part of a comprehensive risk profile or a clinically redundant practice?Childhood bullying involvement predicts low-grade systemic inflammation into adulthood.Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis.Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.Utilisation of search filters in systematic reviews of prognosis questions.Time variability of C-reactive protein: implications for clinical risk stratification.Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.Practical use of the Framingham risk score in primary prevention: Canadian perspective A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.Self-rated health and C-reactive protein in young adults Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis C-reactive protein concentration predicts mortality in type 2 diabetes: the Diabetes Heart Study.Association of C-reactive protein with cardiovascular disease mortality according to diabetes status: pooled analyses of 25,979 participants from four U.K. prospective cohort studies.Mean platelet volume is associated with disease severity in patients with obstructive sleep apnea syndrome.Clinical utility of novel biomarkers in the prediction of coronary heart disease.Diagnosis of Coronary Heart Diseases Using Gene Expression Profiling; Stable Coronary Artery Disease, Cardiac Ischemia with and without Myocardial Necrosis.Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease: A Meta-Analysis.Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis.Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile.Metabolic biomarkers for predicting cardiovascular disease.Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis Commentary: C-reactive protein and risk prediction--moving beyond associations to assessing predictive utility and clinical usefulness.C-reactive protein and prognosis in diabetes: getting to the heart of the matter Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation.Screening for heart disease: C-reactive protein versus coronary artery calcium.

P2860

Q21284725-90F3FD42-375A-40DD-9D23-002229FD1C3F Q24289043-FE52C2CA-3DF4-4CC0-A43C-5EBC3C92C36E Q24594814-7854B256-17B2-4090-93CB-DC3171110138 Q24649709-C8EF9894-AB8A-4889-91BC-2786A3789F1E Q26744435-0B32C432-8D49-46EF-BF77-ADA7F3926605 Q26785938-CE23C9C8-36E7-4211-B56F-59D798A03B5D Q26860959-0B4EE1B2-E580-415D-8928-19154EFF647E Q26865722-C6EADEEA-4CB4-4A84-9EF4-3381E0D26A83 Q28751824-57554832-9F4F-4D55-9C17-4BC834D61C6C Q33528966-F15772C3-8A3B-4E6E-B005-93C873935CE0 Q33694393-26AC4BD9-6EB2-4582-ADC4-4BC268E847CB Q33703000-8BF7AA6B-1C82-4C7B-A689-BF69AF8DA5EF Q33775363-82C3973A-D7F8-4A17-8AD1-F18707080505 Q33791968-AD094C49-D165-44D9-B831-1D484AC7044A Q33931558-4FBD3A79-C701-4DB8-8764-705CD25CB6C7 Q33981152-ECDB539F-ACD2-4AB8-80E9-FE5F4B5F96F1 Q34021492-76CB0811-948A-4BD0-9EEC-BBCB2FCB3C1A Q34486542-D65B84BA-06C2-4552-9C65-E317390017CA Q34665888-5D4F89C3-8187-4B24-8C3A-56DE7F3C4F77 Q34695711-29A5F442-A02A-412E-9AD2-5B2FDE243D10 Q34791770-5515C3BD-FE85-4C33-999B-543A1E283857 Q34988695-ED816435-1D02-480B-AA5A-8B4E1B67007E Q35035521-9CA54E8A-B7E6-4A17-87CC-FBC9E48E024F Q35099546-214BCA35-B8AD-425D-A3CC-396608FFAC67 Q35182277-CFA78592-ADC6-4B15-8674-5C358579E43B Q35278810-86B982DF-36F6-4FF3-A384-3069A5AA578A Q35688195-2BF38DC1-62F7-40BA-AF41-FE18AEF30C65 Q35834138-25755EC1-73A6-494D-B546-F1C9D02DA8A3 Q35925691-83EF1F46-4602-4D7F-BC43-49E97C7D63C2 Q35940654-D411986A-586E-4909-872E-8B4600EBB06E Q36098818-592A3D8C-60C5-42AB-B46F-F40B8A632E9F Q36195002-BDBA658A-BC7B-4D4F-9C59-61222F44F6CD Q36253279-B9AAD357-DFCC-4214-9A09-2B5773C2C86F Q36344191-0231405E-EDC2-4F6C-A2DF-7E075D786DD1 Q36584772-E53AC7F4-5E0B-4CA9-A007-D301CF0FF76B Q36650429-6B1C0453-0079-42E3-A42A-9A94BB458D9B Q37090894-D6874C3D-E2F7-46BC-8AD4-7B070B52A25A Q37141791-BC45CB39-4F5A-4CF8-9F17-40B741BA4A65 Q37183098-2F368D3C-3AA2-47B0-A54C-A8BCE6C318AC Q37656297-82449F11-EC4E-413A-B391-6D00CC678B5C

P2860

Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

http://www.wikidata.org/entity/Q33377856

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@ast

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@en

type

label

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@ast

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@en

prefLabel

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@ast

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@en

P1433

Q33377856-074B0BA8-E9B7-4551-B522-0C4FEA74AFDC

P1476

Q33377856-FBE1E050-647C-4F2B-B0D0-FA70657FA5AE

P2093

Q33377856-346AFDDC-8E81-48BC-8918-8B06F7C901A3

Q33377856-34BEFC0D-8E69-442A-A346-B691A32A9C20

Q33377856-5AA7221A-0BC1-4226-9FA4-2D60E2D4AA6D

Q33377856-7BA412F3-7693-455C-8B8A-1C2972EE1223

Q33377856-818DA57A-8C6E-415D-849B-A4F23382D2F6

Q33377856-C5A63502-AB32-4117-A4D9-60624D2EB8DF

Q33377856-C8ABE919-DA35-4EAE-8FB1-1E80D123A6D5

P2860

Q33377856-029095F7-5304-42E1-875D-5E1B3D57B377

Q33377856-031156DD-2ACD-463B-B49B-CFD53210FB4C

Q33377856-0358AC9C-2DC8-467E-8F7F-22A853330411

Q33377856-07D385FB-B619-4A7A-A8B9-5DDC3EC26862

Q33377856-0B77414B-BC0C-40D3-BCCE-D3069B3570C0

Q33377856-0E80CE8C-E110-47F7-93A5-9EDC432433E3

Q33377856-247AACF0-3460-4442-A2EC-23F31203A141

Q33377856-2562D7F5-A1D4-4211-A0D7-AD0360F9D8C8

Q33377856-2E845B4F-CE72-4A0F-BA23-59C1B8245DC6

Q33377856-2E85AA40-D880-4C06-BED1-3317BAFDF035

P304

Q33377856-EE7081A8-8F2E-42F4-9F7B-111994CDA526

P31

Q33377856-8E040349-5F3F-4DB8-8534-908707F1CCDF

P356

Q33377856-1C490DCB-5229-419C-9BB0-8E72366396BC

P433

Q33377856-BEC23B81-0383-496E-82D9-05571C671FE9

P478

Q33377856-6BF27844-9D5C-4B58-B9A4-FA9920B8F0AC

P50

Q33377856-012E5D7A-D5AE-4F1D-98BD-9F13662A98FE

Q33377856-25F84B3E-BB53-4785-9882-962AE100D714

Q33377856-426216C3-DDD1-4466-9B24-B805777FAF3D

Q33377856-4ADA8F09-2905-49C5-B75A-E9082C92A8D9

Q33377856-99AF5906-D87D-48CB-BFF0-91E2FEF936AC

Q33377856-9CF5B333-CEA1-4F8F-B4DF-79C68AE93F34

P577

Q33377856-B1AA84FF-6396-4B53-869B-017963B56759

P5875

Q33377856-34AF4E6E-5917-4711-8DD2-914321FE77AD

P698

Q33377856-8AD79702-4A58-42FE-BBE3-84BA2FBE37AF

P932

Q33377856-ECD54CC7-D341-4253-BDF4-55A694FD7DDD

P356

P1433

International Journal of Epidemiology

P1476

Critical appraisal of CRP meas ...... iew of 31 prospective cohorts.

@en

P2093

Ann Rumley

http://www.w3.org/2001/XMLSchema#string

F Gerald R Fowkes

http://www.w3.org/2001/XMLSchema#string

Gordon D Lowe

http://www.w3.org/2001/XMLSchema#string

Jackie A Cooper

http://www.w3.org/2001/XMLSchema#string

John E Deanfield

http://www.w3.org/2001/XMLSchema#string

Juan P Casas

http://www.w3.org/2001/XMLSchema#string

Reecha Sofat

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

When can a risk factor be used as a worthwhile screening test?

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

P304

217-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/IJE/DYN217

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Aroon Hingorani

Stephen E Humphries

Valerie McCormack

Ioanna Tzoulaki

P577

2008-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23394568

http://www.w3.org/2001/XMLSchema#string

P698

18930961

http://www.w3.org/2001/XMLSchema#string

P932

2639366

http://www.w3.org/2001/XMLSchema#string